Health ❯ Pharmaceuticals

Generic Drugs

Semaglutide Diabetes Treatment Market Dynamics Atorvastatin FDA Regulations Access to Medicines US Government Programs Weight Loss GLP-1 Receptor Agonists Market Availability

Sildenafil May Limit Cancer Spread by Disrupting Tumor Cholesterol

Researchers identify a cholesterol‑handling pathway that could be targeted to weaken metastatic cancer cells.

NITI Aayog Says India’s Pharma Sector Relies on China and Must Move Up the Value Chain

FDA Asks Indian Drugmakers to Supply Ifosfamide for US Cancer Shortage

Novo Nordisk Cuts Ozempic Price for Uninsured Canadians as Generics Hit Shelves

Generic Semaglutide Hits Canadian Pharmacy Shelves

Health Canada Approves Apotex’s Generic Ozempic, Opening Canada’s Market to Lower-Cost Semaglutide

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Canada Opens Path to Generic Ozempic as Health Canada Weighs Nine Applications

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Class II Recall Targets 142,000 Bottles of Ascend’s Atorvastatin

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

Chinese Weight-Loss Drug Suppliers Pivot to Generics as U.S. Crackdown Ends Copycat Boom

EU Fines Teva $503 Million for Blocking MS Drug Competition